<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1319">
  <stage>Registered</stage>
  <submitdate>5/10/2006</submitdate>
  <approvaldate>5/10/2006</approvaldate>
  <nctid>NCT00385073</nctid>
  <trial_identification>
    <studytitle>Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinsons Disease</studytitle>
    <scientifictitle>Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinsons Disease</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>126/05</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Parkinson's Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Parkinson's disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes />
  <eligibility>
    <inclusivecriteria>-  Early Parkinson's Disease,

          -  Able to provide informed consent,

          -  able to complete exercise diaries for 6 months,

          -  no medications or on levo-dopa</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Not on dopamine agonists,</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration>Longitudinal</duration>
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Royal Talbot Rehabilitation Centre - Melbourne</hospital>
    <postcode> - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Participants will complete a self-selected intensity of exercising over a 6 month period,
      with detailed clinical assessments at commencement and completion to determine the rate of
      progression of parkinsonism and gait abnormalities</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00385073</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>mary m galea, PgD</name>
      <address>Austin Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>mary m Galea, PhD</name>
      <address />
      <phone>0061383444171</phone>
      <fax />
      <email>m.galea@unimelb.edu.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>